Showing results (21-30 of 166) with videos related to
Sort By:
Pageof 17
Plos One|August 24, 2018
Body composition measurements and risk of hematological malignancies: A population-based cohort study during 20 years of follow-upHannes Hagström, Anna Andreasson, Axel C Carlsson, et al.Leukemia & Lymphoma|June 3, 2021
Targeted genomic investigations in a population-based cohort of mantle cell lymphoma reveal novel clinically relevant targetsJoana M Rodrigues, Anna Porwit, May Hassan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Immunohistochemical expression of CD23 and CD40 may identify prognostically favorable subgroups of diffuse large B-cell lymphoma: a Nordic Lymphoma Group StudyJohan Linderoth, Mats Jerkeman, Eva Cavallin-Ståhl, et al.BMC Cancer|March 18, 2006
Midline carcinoma with t(15;19) and BRD4-NUT fusion oncogene in a 30-year-old female with response to docetaxel and radiotherapyJens Engleson, Maria Soller, Ioannis Panagopoulos, et al.Blood|October 16, 2007
Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphomaSara Ek, Michael Dictor, Mats Jerkeman, et al.Experimental Cell Research|February 18, 2011
Inhibition of geranylgeranylation mediates sensitivity to CHOP-induced cell death of DLBCL cell linesMalin Ageberg, Karin Rydström, Ola Lindén, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 2, 2010
Prognostic impact of protein kinase C beta II expression in R-CHOP-treated diffuse large B-cell lymphoma patientsSari Riihijärvi, Satu Koivula, Heidi Nyman, et al.British Journal of Haematology|November 14, 2019
Comorbidities and sex differences in causes of death among mantle cell lymphoma patients - A nationwide population-based cohort studyIngrid Glimelius, Karin E Smedby, Sandra Eloranta, et al.BMC Cancer|June 29, 2012
Expanded clinical and experimental use of SOX11 - using a monoclonal antibodyLena Nordström, Ulrika Andréasson, Mats Jerkeman, et al.British Journal of Cancer|August 23, 2022
Patient trajectories after diagnosis of diffuse large B-cell lymphoma-a multistate modelling approach to estimate the chance of lasting remissionSara Ekberg, Michael Crowther, Sara Harrysson, et al.Pageof 17